

Fundamental dimension Equity attribute | LXFRPeer $17.28▲+0.29% Cap $466.4MP/E 57.6x QuantScore52/100 | ACCOLeader $4.57▼-2.35% Cap $421.8MP/E 7.2x QuantScore63/100 | BWPeer $4.15▼-1.66% Cap $618.2MP/E -4.8x QuantScore25/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
71/100 |
96/100 |
23/100 |
Valuation Multiples, PEG & DCF upside | 37/100 | 100/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 68/100 | 40/100 | 14/100 |
Growth Revenue / earnings growth & margins | 3/100 | 27/100 | 37/100 |
Sentiment Analyst ratings, targets & revisions | 80/100 | 52/100 | 50/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 57.6x | 7.2x | -4.8x |
Forward P/E (next FY) | 16.9x | 5.2x | 28.6x |
EV / EBITDA (TTM) | 14.9x | 6.9x | -20.3x |
Price / Sales | 1.3x | 0.3x | 0.7x |
Price / Free Cash Flow | 28.3x | 8.1x | -10.6x |
PEG ratio | -0.86 | 0.28 | -0.16 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 8 / 9 | 4 / 9 |
Altman Z-Score | 3.51 (Safe) | 0.83 (Distress) | -1.09 (Distress) |
Total debt / equity | 0.26 | 1.46 | 5.31 |
Quick ratio | 1.1x | 1.2x | 1.3x |
Interest coverage | 11.4x | 2.1x | 1.3x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -1.9% | -8.5% | -18.1% |
Net income growth YoY | -58.2% | +140.6% | +39.6% |
Gross margin (TTM) | 24.8% | 31.2% | 20.0% |
Operating margin (FY) | 9.3% | 7.1% | 3.9% |
FCF margin (FY) | 6.8% | 3.3% | -14.6% |
5. Trailing price performancePrice change over period |
1M return | +0.2% | +6.3% | -32.7% |
3M return | +1.3% | +14.3% | -56.9% |
6M return | +31.5% | +38.1% | -71.4% |
Year to date | +27.7% | +22.5% | -34.5% |
1Y return | +27.2% | +10.4% | +19.9% |
3Y return | +95.9% | -8.2% | +69.4% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $7.12 -58.8% premium | $14.10 +208.5% upside | $-0.4113 -109.9% premium |
Wall Street consensus target | — — | $6.00 +31.3% · range $6.00–$6.00 | $21.50 +418.1% · range $20.00–$23.00 |
Consensus stance | 78% Buy22% Hold-0% Sell | 43% Buy57% Hold0% Sell | 14% Buy71% Hold14% Sell |